Lieming Ding
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
Papers in
- Oncology 37
- Lung Cancer Research Studies 14
- Colorectal Cancer Treatments and Studies 9
- HER2/EGFR in Cancer Research 8
- Pancreatic and Hepatic Oncology Research 7
-
- Lung Cancer Treatments and Mutations 29
- Lung Cancer Diagnosis and Treatment 9
- Gastric Cancer Management and Outcomes 6
- Co-authors
- Fenlai Tan (16 shared papers)Yinxiang Wang (5 shared papers)Guojian Xie (2 shared papers)Yanping Wang (3 shared papers)Xiaobin Yuan (4 shared papers)Dechang Wang (1 shared paper)Xiaoyan Shen (1 shared paper)Wei He (1 shared paper)
- Journals
- Cancer Research (9 papers)Journal of Clinical Oncology (9 papers)Lung Cancer (3 papers)The Oncologist (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Lieming Ding
51 papers receiving 607 citations
Peers
Comparison fields: 5 of 62
- Oncology 325
- Pulmonary and Respiratory Medicine 369
- Molecular Biology 194
- Cancer Research 42
- Organic Chemistry 79
Countries citing papers authored by Lieming Ding
This map shows the geographic impact of Lieming Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lieming Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lieming Ding more than expected).
Fields of papers citing papers by Lieming Ding
This network shows the impact of papers produced by Lieming Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lieming Ding. The network helps show where Lieming Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Lieming Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 115 | |
| 2 | 2012 | 46 | |
| 3 | 2016 | 45 | |
| 4 | 2015 | 34 | |
| 5 | 2014 | 31 | |
| 6 | 2018 | 30 | |
| 7 | 2016 | 26 | |
| 8 | 2021 | 21 | |
| 9 | 2002 | 20 | |
| 10 | 2022 | 19 | |
| 11 | 2023 | 15 | |
| 12 | 2020 | 15 | |
| 13 | Potential predictive value of serum targeted metabolites and concurrently mutated genes for EGFR-TKI therapeutic efficacy in lung adenocarcinoma patients with EGFR sensitizing mutations. | 2020 | 14 |
| 14 | 2018 | 12 | |
| 15 | 2022 | 12 | |
| 16 | 2016 | 11 | |
| 17 | 2022 | 10 | |
| 18 | 2020 | 10 | |
| 19 | 2020 | 9 | |
| 20 | 2021 | 9 |
About Lieming Ding
Lieming Ding is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 53 papers that have together received 616 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (29 papers), Lung Cancer Research Studies (14 papers), Colorectal Cancer Treatments and Studies (9 papers), Lung Cancer Diagnosis and Treatment (9 papers), HER2/EGFR in Cancer Research (8 papers), Pancreatic and Hepatic Oncology Research (7 papers), Gastric Cancer Management and Outcomes (6 papers) and Cancer therapeutics and mechanisms (5 papers). The work is most often cited by research in Oncology (325 citations), Pulmonary and Respiratory Medicine (369 citations), Molecular Biology (194 citations), Cancer Research (42 citations) and Organic Chemistry (79 citations). Lieming Ding has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Fenlai Tan, Yinxiang Wang, Guojian Xie, Yanping Wang, Xiaobin Yuan, Dechang Wang, Xiaoyan Shen, Wei He, Xiaodong Zhang and Bin Wu. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Lung Cancer, The Oncologist and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.